Phase II Study Evaluating the Efficacy and Safety of KX-826

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a multi-center, randomized, double-blind, placebo-controlled Phase II clinical study of KX-826 in Chinese adult male patients with AGA.
Epistemonikos ID: b8ed8ee53a4039fe788c6973867c7b5916d80cc2
First added on: May 15, 2024